Versant Ventures
Helicos Updates Filing for Selling Shareholders
The new preliminary prospectus offers for sale around 9.6 million shares by shareholders of the firm. Helicos won't receive any proceeds from the sale.
Short Reads: Feb 17, 2009
Premium
Life Technologies, Max Planck Institute for Evolutionary Anthropology, 454 Life Sciences, Applied Biosystems, Baylor College of Medicine, University of Bristol, University of Liverpool, John Innes Centre, Helicos BioSciences, Febit, and more…
Helicos Files Shares for Sale by Investors from December Placement
Helicos filed the prospectus for 68.4 million shares held by investors who participated in a private placement in December. The firm would receive none of the proceeds from the sale of those shares, if any of them are sold.
scientists may be years away from developing genomics-based medical treatments and therapies, but the hype surrounding the news that rese